Skip to main content
LOGIN
Solutions
Solutions
Solutions for Integrated Delivery Networks
Solutions for Community Cancer Centers
Solutions for Academic Institutions and NCI-Designated Cancer Centers
Solutions for Life Science
Resources
Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Schedule A Demo
Solutions
Driving Timely, Precision Cancer Care for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Enabling the Right Treatment at the Right Time for Every Cancer Patient
Explore the OncoLens Platform
Learn More
Resources
Project ECHO® Learning Series
Evolving Role of Bispecific Antibodies as Cancer Therapy
Join ACCC, Physicians' Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a five-part complimentary tele-mentoring series on the optimal use of bispecific antibodies as cancer immunotherapies.
VIEW RECORDED SESSIONS
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
3,000,000+
Oncology patients under care within the network
85-90%
Accuracy in AI-driven Patient ID from unstructured data
250,000+
Multidisciplinary case discussions
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule a Demo
Careers
Solutions
Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Next Level
Multidisciplinary Cancer Care
Explore the OncoLens Platform
Resources
Project ECHO® Learning Series
Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
LEARN MORE and REGISTER
Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
Powered by OncoLens.
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
2,000,000+
Patients under Care in 200+ Cancer Centers
118,000+
Multidisciplinary Case Discussions
19,000+
Comprehensive Tumor Conferences
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule A Demo
SCHEDULE A DEMO
LOGIN
OncoLens
Resources
ALL
Blog
Case Studies
CME
Education
News and Events
1
2
3
4
5
Aug 26, 2022 | CME
Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies
Read More
Jul 19, 2022 | News and Events
MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally
Read More
May 12, 2022 | CME
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Read More
Mar 15, 2022 | Education
Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing
Read More
Mar 08, 2022 | Education
Quality Improvement Program Webinar—NSCLC Biomarker Testing
Read More
Feb 04, 2022 | News and Events
The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform
Read More
Jan 20, 2022 | News and Events
OncoLens Platform Critical to Meeting the CoC’s Continuous Quality Improvement Requirements
Read More
Dec 27, 2021 | Blog
2022 Multidisciplinary Cancer Care Top Five Trends
Read More
Dec 17, 2021 | News and Events
OncoLens Celebrates the CoC’s 100th Anniversary
Read More
Sep 24, 2021 | Case Studies
Results of a Multi-State, Multi-Institution Implementation of a Multidisciplinary Conference Quality Measurement Tool
Read More
Aug 17, 2021 | News and Events
New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home
Read More
Jun 04, 2021 | Case Studies
Time-Saving Opportunities through Tumor Board and Cancer Registry Integration
Read More
Jun 01, 2021 | CME
Molecular Testing in the Community Oncology Setting
Read More
Apr 01, 2021 | Education
Lung Cancer Patient with 3 EGFR Mutations
Read More
Apr 01, 2021 | Education
Ovarian Cancer Patient with Somatic BRCA1 Reversion Mutation
Read More
Apr 01, 2021 | Education
Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations
Read More
Mar 01, 2021 | Education
NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients
Read More
Mar 01, 2021 | Education
Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result
Read More
Mar 01, 2021 | Education
NSCLC Patient and Adjuvant Chemotherapy
Read More
Feb 01, 2021 | Education
Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results
Read More
Feb 01, 2021 | Education
Patient with NSCLC Who Recurred within a Year
Read More
1
2
3
4
5
3477
